Rising Incidence likely to Drive Thyroid Gland Disorders Treatment Market to USD 2,085 Million by 2020

Rising Incidence likely to Drive Thyroid Gland Disorders Treatment Market to USD 2,085 Million by 2020

According to a market research report published by iHealthcareAnalyst, Inc., Thyroid Gland Disorders Treatment Market – Global Thyroid Gland Disorder Types Analysis and Forecast 2016-2020, the global thyroid gland disorders treatment market was valued at USD 1,768 Million in 2015 and is estimated to reach USD 2,085 Million by 2020, at a CAGR of 3.4% from 2016 to 2020.

Browse the Thyroid Gland Disorders Treatment Market – Global Thyroid Gland Disorder Types Analysis and Forecast 2016-2020 at https://www.ihealthcareanalyst.com/report/thyroid-gland-disorders-treatment-market/

The thyroid gland manufactures hormones that regulate the body’s metabolism (the process of creating and using energy). There are several different disorders that can arise when the thyroid produces too much hormone (hyperthyroidism) or not enough (hypothyroidism). Four common thyroid disorders include Hashimoto’s disease, Graves’ disease, goiter, and thyroid nodules. The most serious form of hypothyroidism is called myxedema, which can lead to coma and even death. An underactive thyroid gland affects all organs and functions within the body, leading to both physical and emotional symptoms. The global thyroid gland disorders treatment market report estimates the market size (Revenue USD million – 2013 to 2020) for key market segments based on the disorder types (hyperthyroidism, hypothyroidism, imidazole, levothyroxine, liothyronine, and propacil), and forecasts growth trends (CAGR% – 2016 to 2020). It also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends.

The global thyroid gland disorders treatment market is segmented as:

  1. Disorder/Drug Type
    • Hyperthyroidism
      • Imidazole
      • Propacil
    • Hypothyroidism
      • Levothyroxine
      • Liothyronine
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • AbbVie, Inc.
    • Allergan plc
    • GlaxoSmithKline plc
    • Lannett Company, Inc.
    • Merck KGaA
    • Mylan N.V.
    • Novartis International AG
    • Pfizer, Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Co., Ltd.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:20:20+00:00 Categories: Press Releases|